Compare ResMed Inc. (RMD) vs Vipshop Holdings Ltd - ADR (VIPS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ResMed Inc. vs Vipshop Holdings Ltd - ADR — how do they compare? ResMed Inc. trades at $225.92 (market cap $31.78B), while Vipshop Holdings Ltd - ADR trades at $12.71 (market cap $6.07B). The key difference: ResMed Inc. is far larger — about 5.2× Vipshop Holdings Ltd - ADR's market cap, and Vipshop Holdings Ltd - ADR pays the higher dividend (4.86%). Which is the better fit depends on your goals — on Pluang, investors hold ResMed Inc. for 51 Days and Vipshop Holdings Ltd - ADR for 49 Days on average.
| RMD | VIPS | |
|---|---|---|
Market Cap | $31.78B | $6.07B |
Volume | 1,128,382 | 3,134,219 |
Sector | Health | Consumer Cyclical |
52-Week High | $277.88 | $20.29 |
52-Week Low | $182.82 | $12.09 |
Typical Hold Time | 51 Days | 49 Days |
Enterprise Value | $31.14B | $2.90B |
Dividend Yield | 1.17% | 4.86% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ResMed (RMD) trades at $225.98, up 2.4% today, with a bullish technical outlook supported by moving averages and strong fundamentals. The company reported revenue of $5.15B in 2025, with net income of $1.40B and robust margins. Recent earnings beats and a dividend announcement highlight operational strength, while analyst consensus leans positive with a $242.70 price target.
Outlook remains favorable due to consistent EPS growth and market share gains, though risks include competitive pressures and ongoing legal investigations. The stock offers growth potential from healthcare demand tailwinds, but investors should monitor execution against guidance and macroeconomic factors affecting medical device spending.
Vipshop Holdings trades at $12.77, showing modest daily gains of 0.16%. The stock presents compelling value with a P/E of 4.12 and P/S of 0.41, significantly below sector averages. Recent earnings showed mixed results with Q2 2026 missing expectations, but the company maintains strong profitability with 9.82% net margins and 24.44% ROE. Technical indicators show a bullish overall signal despite recent price consolidation near key support levels.
The investment case balances deep valuation discounts against growth challenges. Analyst consensus targets $16.17 (26% upside) with 54% buy ratings, though recent earnings misses and consumer spending concerns warrant caution. Strong cash generation and shareholder returns provide downside protection, making VIPS attractive for value investors despite near-term headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →About Vipshop Holdings Ltd - ADR
Vipshop Holdings Ltd is an online discount retailer for brands in China. The company offers branded products to consumers in China through flash sales on its vipshop.com, vip.com and lefeng.com websites. Flash sales represent an online retail format combining the advantages of e-commerce and discount sales through selling a finite quantity of discounted products or services online for a limited period of time. It deals in a wide range of products and services for consumers specializing in branded cosmetics, apparel, healthcare products, food and other consumer products. Its operating segment includes Vip.com and Shan Shan Outlets. The company generates maximum revenue from Vip.com segment.
Read more on VIPS →
